MED logo

Medartis Holding AG Stock Price

SWX:MED Community·CHF 1.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

MED Share Price Performance

CHF 88.30
31.70 (56.01%)
4.3% undervalued intrinsic discount
CHF 92.30
Fair Value
CHF 88.30
31.70 (56.01%)
1.3% undervalued intrinsic discount
CHF 89.47
Fair Value
Price CHF 88.30
AnalystConsensusTarget CHF 89.47

MED Community Narratives

AnalystConsensusTarget·
Fair Value CHF 92.3 4.3% undervalued intrinsic discount

Orthopedic Demand And Digital Solutions Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Recent MED News & Updates

Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet

Sep 25
Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet

Earnings Update: Medartis Holding AG (VTX:MED) Just Reported And Analysts Are Trimming Their Forecasts

Aug 22
Earnings Update: Medartis Holding AG (VTX:MED) Just Reported And Analysts Are Trimming Their Forecasts

Investors Continue Waiting On Sidelines For Medartis Holding AG (VTX:MED)

Aug 21
Investors Continue Waiting On Sidelines For Medartis Holding AG (VTX:MED)

Returns At Medartis Holding (VTX:MED) Appear To Be Weighed Down

Apr 13
Returns At Medartis Holding (VTX:MED) Appear To Be Weighed Down

We Think Medartis Holding's (VTX:MED) Robust Earnings Are Conservative

Mar 26
We Think Medartis Holding's (VTX:MED) Robust Earnings Are Conservative
User avatar

New CEO And Keri Touch Launch Will Accelerate US And LATAM Expansion

The strategic initiatives under new leadership in the U.S. and LATAM, including product launches and acquisitions, aim to improve revenue and market share.

Medartis Holding AG Key Details

CHF 236.3m

Revenue

CHF 49.4m

Cost of Revenue

CHF 187.0m

Gross Profit

CHF 187.4m

Other Expenses

-CHF 487.0k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 17, 2026
Earnings per share (EPS)
-0.039
Gross Margin
79.11%
Net Profit Margin
-0.21%
Debt/Equity Ratio
44.3%

Medartis Holding AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

1 Risk
1 Reward

About MED

Founded
1997
Employees
1158
CEO
Matthias Schupp
WebsiteView website
www.medartis.com

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Swiss Market Performance

  • 7 Days: 3.9%
  • 3 Months: 3.6%
  • 1 Year: 3.4%
  • Year to Date: 6.3%
The market is up 3.9% in the last 7 days, led by the Healthcare and all sectors gaining ground. As for the past 12 months, the market is up 3.4%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›